Mercier F J, Riley E T, Frederickson W L, Roger-Christoph S, Benhamou D, Cohen S E
Département d'Anesthésie-Réanimation, Hĵpital Antoine Béclère, Clamart France.
Anesthesiology. 2001 Sep;95(3):668-74. doi: 10.1097/00000542-200109000-00020.
Because ephedrine infusion (2 mg/min) does not adequately prevent spinal hypotension during cesarean delivery, the authors investigated whether adding phenylephrine would improve its efficacy.
Thirty-nine parturients with American Society of Anesthesiologists physical status I-II who were scheduled for cesarean delivery received a crystalloid preload of 15 ml/kg. Spinal anesthesia was performed using 11 mg hyperbaric bupivacaine, 2.5 microg sufentanil, and 0.1 mg morphine. Maternal heart rate and systolic blood pressure were measured at frequent intervals. A vasopressor infusion was started immediately after spinal injection of either 2 mg/min ephedrine plus 10 microg/min phenylephrine or 2 mg/min ephedrine alone. Treatments were assigned randomly in a double-blind fashion. The infusion rate was adjusted according to systolic blood pressure using a predefined algorithm. Hypotension, defined as systolic blood pressure less than 100 mmHg and less than 80% of baseline, was treated with 6 mg ephedrine bolus doses.
Hypotension occurred less frequently in the ephedrine-phenylephrine group than in the ephedrine-alone group: 37% versus 75% (P = 0.02). Ephedrine (36+/-16 mg, mean +/- SD) plus 178+/-81 microg phenylephrine was infused in former group, whereas 54+/-18 mg ephedrine was infused in the latter. Median supplemental ephedrine requirements and nausea scores (0-3) were less in the ephedrine-phenylephrine group (0 vs. 12 mg, P = 0.02; and 0 vs. 1.5, P = 0.01, respectively). Umbilical artery pH values were significantly higher in the ephedrine-phenylephrine group than in the group that received ephedrine alone (7.24 vs. 7.19). Apgar scores were similarly good in both groups.
Phenylephrine added to an infusion of ephedrine halved the incidence of hypotension and increased umbilical cord pH.
由于剖宫产术中麻黄碱输注(2毫克/分钟)不足以有效预防脊髓性低血压,作者研究了添加去氧肾上腺素是否能提高其疗效。
39例美国麻醉医师协会身体状况分级为I-II级、计划行剖宫产的产妇,静脉输注15毫升/千克的晶体液进行预负荷。采用11毫克重比重布比卡因、2.5微克舒芬太尼和0.1毫克吗啡实施脊髓麻醉。频繁测量产妇心率和收缩压。脊髓注射后立即开始血管升压药输注,一组为2毫克/分钟麻黄碱加10微克/分钟去氧肾上腺素,另一组为单独2毫克/分钟麻黄碱。采用双盲法随机分配治疗方案。根据预设算法,依据收缩压调整输注速率。低血压定义为收缩压低于100毫米汞柱且低于基线值的80%,采用6毫克麻黄碱推注进行治疗。
麻黄碱-去氧肾上腺素组低血压发生率低于单独使用麻黄碱组:分别为37%和75%(P = 0.02)。前一组输注了36±16毫克(均值±标准差)麻黄碱加178±81微克去氧肾上腺素,后一组输注了54±18毫克麻黄碱。麻黄碱-去氧肾上腺素组的麻黄碱补充需求量中位数和恶心评分(0-3分)较低(分别为0毫克对12毫克,P = 0.02;0分对1.5分,P = 0.01)。麻黄碱-去氧肾上腺素组脐动脉pH值显著高于单独使用麻黄碱组(7.24对7.19)。两组阿氏评分同样良好。
在麻黄碱输注中添加去氧肾上腺素可使低血压发生率减半,并提高脐动脉pH值。